Ishares Msci Spain ETF vs Cassava Sciences Inc — how do they compare? Ishares Msci Spain ETF trades at $62.65, while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Ishares Msci Spain ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| EWP | FLNA | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $62.66 | $4.64 |
52-Week Low | $47.02 | $0.87 |
Market Cap | — | $47.75M |
Enterprise Value | — | -$34.93M |
Signals from Pluang's Aura AI — not financial advice
EWP is trading at $62.66, up 0.58% with a bullish technical signal driven by strong moving average support. The stock shows mixed momentum with overbought RSI readings but positive ADX trend strength. Recent corporate actions include a $0.92 dividend scheduled for June 2026. European market sentiment remains influenced by ECB policy decisions and energy price volatility.
The stock's outlook balances technical strength against fundamental data gaps. European economic resilience and potential short-squeeze dynamics offer upside, while overbought conditions and geopolitical risks present near-term headwinds. Dividend income provides additional shareholder value, though comprehensive financial metrics are needed for full fundamental assessment.
FLNA trades at $0.995, up 3.75% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of -$0.18 beating expectations of -$0.225. Financials show negative cash flows and profitability, with ROE at -55.79% and net income of -$90.97M in 2025. Analyst consensus is strongly positive with 8 buy ratings out of 12.
Despite operational losses, FLNA's consistent earnings beats and strong analyst support suggest potential upside if clinical developments progress. Key risks include sustained cash burn, lack of revenue, and dependence on successful drug trials for Tuberous Sclerosis Complex. The stock remains speculative with high volatility expected.
Trailing returns across standard periods
EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →